Bromocriptine
Alona Crowder, PharmD
,
Aniket Sidhaye, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Bromoctriptine quick-release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and
exercise
Other FDA indications include: prolactin-secreting adenomas, hyperprolactinemia,
acromegaly
, Parkinson’s disease
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Neuroleptic malignant syndrome
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved